CLN8

gene product
C8orf61, EPMR, FLJ39417
This gene encodes a transmembrane protein belonging to a family of proteins containing TLC domains, which are postulated to function in lipid synthesis, transport, or sensing. The protein localizes to the endoplasmic reticulum (ER), and may recycle between the ER and ER-Golgi intermediate compartment. Mutations in this gene are associated with progressive epilepsy with mental retardation (EMPR), which is a subtype of neuronal ceroid lipofuscinoses (NCL). Patients with mutations in this gene have altered levels of sphingolipid and phospholipids in the brain. [provided by RefSeq, Jul 2008]
More gene data

Featured antibodies

Antibodies

 

Filters

Application

Antibodypedia Validation Initiative

Validation method

Reference

Provider

Host

Reactivity

Antibody type

Conjugate

  or   Clear
Enhanced validation
Supportive data in Antibodypedia
Data presented on provider website
Data in Antibodypedia (inconclusive)
Recommended by provider
Validated within AVI
Eligible for validation within AVI
116 antibodies from 19 providers.

Antibody properties

General

Applications

or Cancel
AntibodyRefsTypeWBELICCIPIHCFC
antibodies-online
48 antibodies
Abbkine Scientific Co.Ltd.
1 antibody
NovoPro Bioscience Inc.
1 antibody
Biorbyt
11 antibodies
LifeSpan BioSciences, Inc.
21 antibodies
Aviva Systems Biology
3 antibodies
GeneTex
2 antibodies
Novus Biologicals
2 antibodies
OriGene
2 antibodies
Abgent
1 antibody
ProSci
2 antibodies
Boster Biological Technology
1 antibody
Invitrogen Antibodies
1 antibody
Creative Diagnostics
2 antibodies
MyBioSource
1 antibody
St John's Laboratory
1 antibody
United States Biological
13 antibodies
Sigma-Aldrich
2 antibodies
Abnova Corporation
1 antibody